View source for Martin Babler

[[File:Matinbabler.jpg|200px|thumb|left|Martin Babler]]

==Country==

United States

==Birth - Death==


==Occupation==

Business

==Description==

Chairman, President and Chief Executive Officer of Alumis since 2021.  Board member of Prelude Therapeutics, Omega Alpha SPAC, Neoluken Therapeutics, 89Bio, and several other therapeutic companies.  

==See Also==

* [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]]

==Further Reading/Research==

* https://www.linkedin.com/in/martin-babler-33b48/
* https://ir.89bio.com/news-releases/news-release-details/89bio-appoints-biotech-industry-veteran-martin-babler-its-board
* https://www.youtube.com/watch?v=B_y0BqOu5aU

<html><br />
<a href="#" 
  onclick="
    window.open(
      'https://www.facebook.com/sharer/sharer.php?u='+encodeURIComponent(location.href), 
      'facebook-share-dialog', 
      'width=626,height=436'); 
    return false;">
  Share on Facebook
</a></html>

<html><br />
<a class="twitter-share-button"
  href="https://twitter.com/intent/tweet">
Tweet</a></html